Prolaris
Total Payments
$868,894
Transactions
9,449
Doctors
3,384
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $434,245 | 4,769 | 2,310 |
| 2021 | $434,649 | 4,680 | 2,206 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $543,003 | 41 | 62.5% |
| Food and Beverage | $184,782 | 9,263 | 21.3% |
| Consulting Fee | $77,988 | 68 | 9.0% |
| Honoraria | $27,038 | 17 | 3.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,900 | 10 | 2.6% |
| Travel and Lodging | $13,184 | 50 | 1.5% |
Payments by Type
Research
$543,003
41 transactions
General
$325,891
9,408 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer | MYRIAD GENETIC LABORATORIES, INC. | $285,175 | 0 |
| EndoPredict Extended Endocrine Trial (EXET) | MYRIAD GENETIC LABORATORIES, INC. | $245,145 | 0 |
| EndoPredict Extended Endocrine Trial (EXET) | Myriad Genetic Laboratories, Inc. | $6,970 | 1 |
| Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer | Myriad Genetic Laboratories, Inc. | $5,713 | 0 |
Top Doctors Receiving Payments for Prolaris
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Little Rock, AR | $538,033 | 40 |
| , M.D | Anatomic Pathology & Clinical Pathology | Little Rock, AR | $62,822 | 81 |
| , MD | Urology | Salisbury, MD | $15,487 | 17 |
| , MD | Radiation Oncology | Naples, FL | $15,084 | 23 |
| , M.D | Radiation Oncology | Spokane Valley, WA | $12,265 | 12 |
| , MD, PHD | Radiation Oncology | Salt Lake City, UT | $9,109 | 15 |
| , MD | Urology | Allentown, PA | $8,824 | 14 |
| , DR | Urology | Myrtle Beach, SC | $5,337 | 10 |
| , M.D., PH.D | Urology | Nashville, TN | $4,970 | 1 |
| , M.D., MCH | Urology | Saginaw, MI | $3,363 | 8 |
| , MD | Therapeutic Radiology | Syracuse, NY | $2,479 | 4 |
| , MD | Urology | Decatur, GA | $1,957 | 10 |
| , MD | Urology | Silver Spring, MD | $1,543 | 9 |
| , MD | Chemical Pathology | Royal Oak, MI | $1,400 | 2 |
| , M.D | Urology | Baltimore, MD | $1,398 | 5 |
| , M.D | Radiation Oncology | Pembroke Pines, FL | $1,191 | 9 |
| , M.D., PHD | Student in an Organized Health Care Education/Training Program | Baltimore, MD | $1,100 | 1 |
| , MD | Urology | West Bloomfield, MI | $693.73 | 3 |
| , M.D | Specialist | Anacortes, WA | $594.27 | 11 |
| , M.D | Radiation Oncology | Tampa, FL | $538.49 | 7 |
| , MD | Urology | Ocala, FL | $496.51 | 19 |
| , DO | Urology | Snellville, GA | $491.28 | 5 |
| , MD | Urology | San Antonio, TX | $450.00 | 1 |
| , MD | Urology | Merrillville, IN | $444.57 | 10 |
| , M.D | Radiation Oncology | New York, NY | $432.52 | 4 |
Ad
Manufacturing Companies
- MYRIAD GENETIC LABORATORIES, INC. $530,320
- Myriad Genetic Laboratories, Inc. $338,574
Product Information
- Type Device
- Total Payments $868,894
- Total Doctors 3,384
- Transactions 9,449
About Prolaris
Prolaris is a device associated with $868,894 in payments to 3,384 healthcare providers, recorded across 9,449 transactions in the CMS Open Payments database. The primary manufacturer is Myriad Genetic Laboratories, Inc..
Payment data is available from 2021 to 2022. In 2022, $434,245 was paid across 4,769 transactions to 2,310 doctors.
The most common payment nature for Prolaris is "Unspecified" ($543,003, 62.5% of total).
Prolaris is associated with 4 research studies, including "Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer" ($285,175).